These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 1013683)
1. [The relative therapeutic value of drugs in international comparison: differences between Switzerland and Canada]. Gysling E Schweiz Med Wochenschr; 1976 Nov; 106(46):1609-12. PubMed ID: 1013683 [TBL] [Abstract][Full Text] [Related]
2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate. Piver MS Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011 [TBL] [Abstract][Full Text] [Related]
3. A comparison of new drug availability in Canada and the United States and potential therapeutic implications of differences. Lexchin J Health Policy; 2006 Dec; 79(2-3):214-20. PubMed ID: 16472888 [TBL] [Abstract][Full Text] [Related]
6. [Incidence of drug side effects by symptoms and syndromes. From the experiences of the Comprehensive Hospital Drug Monitoring and the Swiss Drug Side Effect Center. As an example: allergic and pseudo-allergic reactions with mild analgesics and NSAID]. Oberholzer B; Hoigné R; Hartmann K; Capaul R; Egli A; Wymann R; Galeazzi RL; Kuhn M; Künzi UP; Maibach R Ther Umsch; 1993 Jan; 50(1):13-9. PubMed ID: 8378861 [TBL] [Abstract][Full Text] [Related]
7. Clinical equivalency: a health protection branch perspective. Morrison AB; Cook D; Casselman WG Can Med Assoc J; 1973 Oct; 109(8):806-8. PubMed ID: 4746138 [No Abstract] [Full Text] [Related]
8. [Drug prices in Switzerland: European comparison of "comfort" drugs]. Vogt N; Morabia A; Dayer P Schweiz Med Wochenschr; 1993 Nov; 123(47):2251-4. PubMed ID: 8272798 [TBL] [Abstract][Full Text] [Related]
9. New drug approval times and 'therapeutic potential' in Canada, Australia, Sweden and the United States during the period 1992 to 1998. Rawson NS; Kaitin KI Can J Clin Pharmacol; 2000; 7(2):97-101. PubMed ID: 10958705 [TBL] [Abstract][Full Text] [Related]
10. Pseudomembranous colitis following clindamycin therapy. Stratton RD; Lapis JL; Bozymski EM N C Med J; 1976 Mar; 37(3):141-3. PubMed ID: 1062681 [No Abstract] [Full Text] [Related]
11. [Ranking the efficacy of drugs--a question of "class"? It is difficult to determine equivalency of two different treatments]. Liedholm H; Linné AB Lakartidningen; 2002 Sep; 99(36):3492-4, 3497-9, 3502. PubMed ID: 12362748 [TBL] [Abstract][Full Text] [Related]
12. [Side effects of drugs on the respiratory tract: experiences of the Swiss Drug Monitoring Center from 1991 to 1995]. Leuppi JD; Hartmann K; Ciociaro C; Reinhart WH; Kuhn M Praxis (Bern 1994); 1996 Oct; 85(44):1394-7. PubMed ID: 8966444 [TBL] [Abstract][Full Text] [Related]
13. [Fatal adverse reactions of drugs from the pathologic-anatomic viewpoint]. Jansen HH Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1530-40. PubMed ID: 611877 [No Abstract] [Full Text] [Related]
15. Canada to allow production of generic AIDS drugs. Nat Rev Drug Discov; 2003 Nov; 2(11):854. PubMed ID: 14702955 [No Abstract] [Full Text] [Related]
17. [Progress and pseudoprogress in the field of drugs (author's transl)]. Wilbrandt W Ther Umsch; 1974 Nov; 31(11):767-71. PubMed ID: 4428442 [No Abstract] [Full Text] [Related]
18. [Evaluation of pharmacotherapy in general-internal ambulatory care as a possibility of quality control]. Zschokke U; Conen D; Dubach UC Schweiz Med Wochenschr; 1981 Jan; 111(1):14-20. PubMed ID: 7209475 [TBL] [Abstract][Full Text] [Related]
19. How to pay less for prescription drugs. Consum Rep; 1975 Jan; 40(1):48-53. PubMed ID: 1244036 [No Abstract] [Full Text] [Related]